Moscow, Russia

Artur V Valdman

This inventor holds 1 USPTO granted patent. Top assignee: Arzneimittelwerk Dresden Gmbh. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Artur V Valdman. Retrieved from https://idiyas.com/inventor/artur-v-valdman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Artur V Valdman: Innovator in Cerebroprotective Compounds

Introduction

Artur V Valdman is a notable inventor based in Moskau, SU. He has made significant contributions to the field of medicine, particularly in the development of compounds that have a pronounced cerebroprotective effect. His work is essential for the prophylaxis and treatment of cerebral functional disorders.

Latest Patents

Valdman holds a patent for N-acyl-4-phenyl-pyrrolidin-2-ones and the method for preparing these compounds. This invention focuses on N-acetyl-4-phenyl-pyrrolidin-2-ones, which are synthesized by reacting 4-phenyl-pyrrolidin-2-ones with a reactive derivative of a carboxylic acid or by cyclizing N-acylaminobutyric acid derivatives. The pronounced cerebroprotective effect of these compounds makes them valuable in human medicine.

Career Highlights

Valdman is associated with Arzneimittelwerk Dresden GmbH, where he continues to innovate and contribute to the field of medicinal chemistry. His work has garnered attention for its potential applications in treating cerebral disorders.

Collaborations

Some of his notable coworkers include Lothar Zenker and Helmut Wunderlich, who have collaborated with him on various projects.

Conclusion

Artur V Valdman's contributions to the field of cerebroprotective compounds highlight his importance as an inventor. His innovative work continues to pave the way for advancements in the treatment of cerebral functional disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…